Ravulizumab-cwvz (Ultomiris) received a label expansion by the FDA for the treatment of adult neuromyelitis optica spectrum ...
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed ...
Patrick Vermersch, MD, PhD, University of Lille, France details the adverse events observed in the frexalimab trials and the ...
Results are consistent with the authors' prior findings on the possible effects of circadian rhythm on outcomes after ...
This analysis included 119 patients with advanced lung cancer, who were evaluated on 3 facets of physical activity over 14 ...
A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary ...
The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) ...
In this investigation, outcomes of interest were morbidity rate and length of hospital stay or a traumatic injury among a ...
These insights, explain the researchers of the study, complement observational studies, which have previously indicated a ...
Will Shapiro, vice president of data science at Flatiron Health, discusses opportunities to implement artificial intelligence in cancer care.